niacinamide has been researched along with MEA 2a in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| INDOVINA, I | 1 |
| CAUSI, N | 1 |
| Plaza-Menacho, I | 1 |
| Mologni, L | 1 |
| Sala, E | 1 |
| Gambacorti-Passerini, C | 1 |
| Magee, AI | 1 |
| Links, TP | 1 |
| Hofstra, RM | 1 |
| Barford, D | 1 |
| Isacke, CM | 1 |
2 other studies available for niacinamide and MEA 2a
| Article | Year |
|---|---|
[Metabolism of nicotinamide in man. II. Venous tolerance test in inflammatory processes].
Topics: Inflammation; Multiple Endocrine Neoplasia Type 2a; Niacin; Niacinamide; Veins | 1952 |
Sorafenib functions to potently suppress RET tyrosine kinase activity by direct enzymatic inhibition and promoting RET lysosomal degradation independent of proteasomal targeting.
Topics: Benzenesulfonates; Cell Line; Cell Line, Tumor; Cell Proliferation; Humans; Inhibitory Concentration | 2007 |